Literature DB >> 16194531

Redistribution of mu-opioid receptors in C1 adrenergic neurons following chronic administration of morphine.

Carrie T Drake1, Sue A Aicher, Fritzline L Montalmant, Teresa A Milner.   

Abstract

Neurons in the rostral ventrolateral medulla (RVLM) are involved in both tonic and reflex control of sympathetic outflow. Many of these neurons express the adrenaline-synthesizing enzyme phenylethanolamine N-methyltransferase (PNMT), and are designated C1 neurons. C1 neurons that contain mu-opioid receptors (MORs) are hyperpolarized by MOR activation and are activated during morphine withdrawal. The present study examined the subcellular distribution of the cloned MOR, MOR1, in rat C1 neurons following chronic morphine treatment, using RVLM sections that were dually labeled for PNMT-immunoperoxidase and MOR1-immunogold. Electron microscopic analysis of the subcellular distribution of MOR1 revealed a lower abundance of plasma membrane-associated MOR1 in C1 dendrites of rats treated with morphine, compared to placebo-treated controls, only in distal dendrites. There were no differences in the size of dual-labeled dendrites between treatment groups or in the overall density of MOR1 within PNMT immunoreactive dendrites between treatment groups. These results suggest that chronic morphine treatment leads to a decreased presence of MOR1 at the cell surface, without a significant reduction in cytoplasmic receptor density. These observations suggest that chronic morphine produces a selective internalization of MOR1 in C1 neurons, without apparent changes in receptor synthesis or trafficking. The reduction of accessible MORs on these neurons may be a mechanism for tolerance with regard to autonomic responses to opioid administration and may facilitate the profound sympathetic hyperactivity that occurs during acute opioid withdrawal.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16194531     DOI: 10.1016/j.expneurol.2005.08.012

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  9 in total

1.  Kainate receptors are primarily postsynaptic to SP-containing axon terminals in the trigeminal dorsal horn.

Authors:  Deborah M Hegarty; Jennifer L Mitchell; Kristin C Swanson; Sue A Aicher
Journal:  Brain Res       Date:  2007-10-04       Impact factor: 3.252

2.  Spinal Opioid Tolerance Depends upon Platelet-Derived Growth Factor Receptor-β Signaling, Not μ-Opioid Receptor Internalization.

Authors:  S Puig; K E Barker; S R Szott; P T Kann; J S Morris; H B Gutstein
Journal:  Mol Pharmacol       Date:  2020-07-28       Impact factor: 4.436

3.  Distribution of CB1 cannabinoid receptors and their relationship with mu-opioid receptors in the rat periaqueductal gray.

Authors:  A R Wilson-Poe; M M Morgan; S A Aicher; D M Hegarty
Journal:  Neuroscience       Date:  2012-04-19       Impact factor: 3.590

Review 4.  Regulation of μ-opioid receptors: desensitization, phosphorylation, internalization, and tolerance.

Authors:  John T Williams; Susan L Ingram; Graeme Henderson; Charles Chavkin; Mark von Zastrow; Stefan Schulz; Thomas Koch; Christopher J Evans; Macdonald J Christie
Journal:  Pharmacol Rev       Date:  2013-01-15       Impact factor: 25.468

Review 5.  In vivo trafficking of endogenous opioid receptors.

Authors:  Yulin Wang; Elisabeth J Van Bockstaele; Lee-Yuan Liu-Chen
Journal:  Life Sci       Date:  2008-10-05       Impact factor: 5.037

6.  Ovarian steroids alter mu opioid receptor trafficking in hippocampal parvalbumin GABAergic interneurons.

Authors:  Annelyn Torres-Reveron; Tanya J Williams; Jeanette D Chapleau; Elizabeth M Waters; Bruce S McEwen; Carrie T Drake; Teresa A Milner
Journal:  Exp Neurol       Date:  2009-06-06       Impact factor: 5.330

7.  Mu-opioid receptor redistribution in the locus coeruleus upon precipitation of withdrawal in opiate-dependent rats.

Authors:  Jillian L Scavone; Elisabeth J Van Bockstaele
Journal:  Anat Rec (Hoboken)       Date:  2009-03       Impact factor: 2.064

8.  Change in functional selectivity of morphine with the development of antinociceptive tolerance.

Authors:  T A Macey; E N Bobeck; K L Suchland; M M Morgan; S L Ingram
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

Review 9.  Cannabinoid receptor 1 signaling in cardiovascular regulating nuclei in the brainstem: A review.

Authors:  Badr M Ibrahim; Abdel A Abdel-Rahman
Journal:  J Adv Res       Date:  2013-04-03       Impact factor: 10.479

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.